Principal Financial Group’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Other funds holding INSY
WS
Principal Financial Group's INSY Position: Q2 2019 in Review
Principal Financial Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 10,988 shares — an estimated $51K sold.
Principal Financial Group first reported a position in INSY in Q4 2017 and held it in 6 quarters. The position peaked at $114K in Q4 2017. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Principal Financial Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Principal Financial Group sold 10,988 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $51K.
- Principal Financial Group first reported a position in Insys Therapeutics, Inc. in Q4 2017 and held it in 6 quarters.
- Principal Financial Group's Insys Therapeutics, Inc. position peaked at $114K in Q4 2017.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Principal Financial Group's 13F filing for Q2 2019, filed 12 Aug 2019.